Back to search
FDAFDA · Food and drugs·Recall number D-0664-2022

Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc.

Published March 23, 2022 · Recall initiated: August 6, 2020

Summary

FDA records drug Class II recall D-0664-2022, published March 23, 2022 and initiated August 6, 2020. Recalling firm: Family Pharmacy of Statesville; Status: Terminated; Reported quantity: 3 bags; Lot: Lot #: 07212020@1 BUD: 8/4/2020; 07232020@2 BUD: 8/6/2020; 07302020@2 BUD: 8/13/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Family Pharmacy of Statesville
Distributor
NC only
Lot
Lot #: 07212020@1 BUD: 8/4/2020; 07232020@2 BUD: 8/6/2020; 07302020@2 BUD: 8/13/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ketamine 50 mg Infusion (LV 1) Solution in 250 mL bags, Rx only, Family Pharmacy of Statesville, Inc. recalled?

Yes. FDA published recall D-0664-2022 on March 23, 2022. Reported hazard: Lack of Assurance of Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone